11.80

5.83% 0.65

After Hours: 11.82 0.02 +0.17%

Oric Pharmaceuticals Inc (ORIC)

Overview News Price History Option Chain Financials Discussions Forecast

Oric Pharmaceuticals Inc stock is traded at $11.80, with a volume of 274.27K. It is up +5.83% in the last 24 hours and up +18.00% over the past month. ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Previous Close:

$11.15

Open:

$11.67

24h Volume:

274.27K

Relative Volume:

0.25

Market Cap:

$1.01B

Revenue:

Net Income/Loss:

$-119.87M

P/E Ratio:

-6.5193

EPS:

-1.81

Net Cash Flow:

$-109.90M

1W Performance:

+5.55%

1M Performance:

+18.00%

6M Performance:

+14.12%

1Y Performance:

+4.80%

1-Day Range:

$11.67

$12.00

1-Week Range:

$10.88

$12.00

52-Week Range:

$3.8951

$14.67

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name

Oric Pharmaceuticals Inc

Sector

Healthcare (1164)

Industry

Biotechnology (653)

Phone

(650) 388-5600

Address

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Employee

122

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

ORIC's Discussions on Twitter

Compare ORIC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ORIC Oric Pharmaceuticals Inc	11.80	950.19M	0	-119.87M	-109.90M	-1.81
VRTX Vertex Pharmaceuticals Inc	476.95	120.73B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	572.39	60.56B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.64	42.41B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	575.42	34.96B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	294.83	31.99B	3.81B	-644.79M	-669.77M	-6.24

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-25	Initiated	Ladenburg Thalmann	Buy
Oct-31-24	Initiated	Wells Fargo	Overweight
Sep-06-24	Initiated	Stifel	Buy
Feb-23-24	Initiated	Cantor Fitzgerald	Overweight
Sep-22-23	Initiated	Wedbush	Outperform
Mar-23-23	Upgrade	H.C. Wainwright	Neutral → Buy
Mar-21-23	Upgrade	Guggenheim	Neutral → Buy
Mar-16-23	Upgrade	Oppenheimer	Perform → Outperform
Jul-18-22	Resumed	Oppenheimer	Perform
Apr-04-22	Upgrade	Citigroup	Neutral → Buy
Mar-25-22	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-22-22	Downgrade	Citigroup	Buy → Neutral
Mar-22-22	Downgrade	Guggenheim	Buy → Neutral
Mar-22-22	Downgrade	Oppenheimer	Outperform → Perform
Jul-06-21	Upgrade	Citigroup	Neutral → Buy
Jan-25-21	Downgrade	Citigroup	Buy → Neutral
Aug-13-20	Initiated	Robert W. Baird	Outperform
Aug-06-20	Upgrade	Citigroup	Neutral → Buy
Aug-03-20	Initiated	H.C. Wainwright	Buy
May-19-20	Initiated	Citigroup	Neutral
May-19-20	Initiated	Guggenheim	Buy
May-19-20	Initiated	JP Morgan	Overweight
May-19-20	Initiated	Jefferies	Buy

View All

Oric Pharmaceuticals Inc Stock (ORIC) Latest News

02:47 AM

What drives ORIC Pharmaceuticals Inc. stock priceExtraordinary performance - Autocar Professional

02:47 AM

11:40 AM

What analysts say about ORIC Pharmaceuticals Inc. stockFree Capital Allocation Plans - Autocar Professional

11:40 AM

07:28 AM

Is ORIC Pharmaceuticals Inc. a good long term investmentFree Trading Psychology Coaching - jammulinksnews.com

07:28 AM

Jul 20, 2025

ORIC Pharmaceuticals Inc. Stock Analysis and ForecastFree Investment Community - printweek.in

Jul 20, 2025

Jul 18, 2025

How high can ORIC Pharmaceuticals Inc. stock price go in 2025Massive Gain Ideas - Newser

Jul 18, 2025

Jul 17, 2025

ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Why ORIC Pharmaceuticals Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser

Jul 16, 2025

Jul 15, 2025

What makes ORIC Pharmaceuticals Inc. stock price move sharplySmart High Yield Swing Trades - Newser

Jul 15, 2025

How ORIC Pharmaceuticals Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025